Cell and Gene Manufacturing and Logistics

1. Your New Control Center For Cell Therapy Process Development 11/6/2025

   Achieve twice the cell yield in early-stage cell therapy development using a proven, scale-down bioreactor model. Parallel power and closed-system operation accelerate results with lower risk.

2. A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches 11/6/2025

   The transition from 2D to 3D cell culture requires a combination of advanced analytical techniques, but aligning new methods with established principles can be challenging.

3. Smart Input Selection And Process Refinement For iPBMCs 11/5/2025

   Improved iPBMC manufacturing boosts TIL therapy reliability, safety, and affordability through donor screening, process refinements, and performance-based cell selection.

4. Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/5/2025

   Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.

5. Why Do So Few Cell Therapies Make The Leap From Lab To GMP? 11/5/2025

   Among other reasons, academic centers have access to sophisticated technology. In contrast, manufacturing suites must use established, validated methods.

6. Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer 11/4/2025

   On episode 115 of Cell & Gene: The Podcast, Host Erin Harris talks to Aliya Omer, Vice President and Global Head of Hematology and Cell Therapy at AstraZeneca, who shares valuable insights from her rich experience leading cell therapy development across multiple top companies.

7. Develop A Cost-Effective cGMP Chemical Sourcing Strategy 11/4/2025

   Outsourcing your cGMP chemical supply chain can significantly reduce capital and operating expenses, minimize production delays, and boost manufacturing productivity through improved sourcing and logistics.

8. Use Cation Exchange Chromatography For High Yields In Vaccine Production 11/4/2025

   Learn how to achieve high yields in vaccine production by using Cation Exchange Chromatography for purifying SARS-CoV-2 spike proteins. This method provides high purity and minimizes protein aggregates.

9. Exosome Production From hMSC Using A Fixed-Bed Bioreactor 11/3/2025

   Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

10. Expansion Of Human Bone Marrow-Derived MSCs 11/3/2025

    Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.